摘要
目的:探讨山西医科大学第一医院泌尿男生殖系恶性肿瘤疾病构成比的变化趋势,为衡量该医院医疗技术水平、合理配置医疗卫生资源和今后泌尿男生殖系恶性肿瘤的防治提供科学依据。方法:收集2008年-2016年9年间太原市常驻人口泌尿男生殖系恶性肿瘤病例,建立Excel数据库进行回顾性分析。结果:泌尿男生殖系恶性肿瘤病例呈明显上升趋势,患者以中老年居多;将男生殖系恶性肿瘤除外后,在泌尿系恶性肿瘤中,男性675例,女性289例,男女比例为2. 341;在2008年—2010年、2011年—2013年、2014年—20016年三个时间段中,构成比排前三的恶性肿瘤均为膀胱癌、肾癌、前列腺癌,从第一个时间段到第三个时间段,膀胱癌的构成比由38. 22%下降至31. 91%,肾癌的构成比由27. 30%上升至31. 21%;在66岁及以上年龄组中,前列腺癌构成比由31. 40%上升至38. 44%。结论:9年来山西医科大学第一医院医疗技术水平明显提高;膀胱癌、肾癌、前列腺癌依然占该院泌尿男生殖系恶性肿瘤的大多数,但是防治重点应由膀胱癌转向肾癌;老年男性应该更注重前列腺癌的防治。
Objective:To explore the trend of constituent ratio of urogenital malignancies in the first hospital of Shanxi Medical University,and measures the medical technology level of the hospital,optimize the configuration of medical and health resources and provide a scientific basis for the prevention and treatment of urogenital malignancy in the future.Methods:To collect cases of urogenital malignancies of TaiYuan resident population in the first hospital of Shanxi Medical University from 2008 to 2016,and establish Excel database for retrospective analysis.Results:The number of hospitalized patients with urogenital malignancies were on the rise,and the patients were mostly elderly.Except for the malignancies of male reproductive system,there were 675 males and 289 females in the urological malignancies,and the ratio of males and females was 2.34∶1.In the three periods,the malignancies of top three were bladder cancer,kidney cancer,prostate cancer.From the first period to the third period,the constituent ratio of bladder cancer increased from 38.22%to 31.91%,and the constituent ratio of kidney cancer rose to 27.30%from 31.21%;In the age group 66 and older,the constituent ratio of prostate cancer increased from 31.40%to 38.44%.Conclusion:the constituent ratio of renal cancer has a tendency to go beyond bladder cancer,and the constituent ratio of prostate cancer in elderly patients rose to the top-one.
作者
王兰
李鸿杰
王翠玲
闫晓清
李卓平
卜威振
李伟
刘鹏
马志方
WANG Lan;LI Hongjie;WANG Cuiling;YAN Xiaoqing;LI Zhuoping;BU Weizhen;LI Wei;LIU Peng;MA Zhifang(First Hospital of Shanxi Medical University,Taiyuan,030001,China)
出处
《临床医药实践》
2019年第2期99-102,156,共5页
Proceeding of Clinical Medicine